By Kathryn Brenzel ( August 26, 2013, 12:27 PM EDT) -- AstraZeneca PLC said on Monday it plans to buy privately held Amplimmune for $500 million, adding the Maryland company's early stage immunotherapy drugs aimed at boosting the British pharmaceutical giant's position in a growing field of cancer treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.